AVL-3288

DB18707InvestigationalSmall molecule

AVL-3288: Overview.

Mechanism: Pharmacologically active on Neuronal acetylcholine receptor subunit alpha-7
Curator reviewed
Formula / weight: C₁₉H₁₅Cl₂N₃O₂ · 388.25 g/mol (avg)
Also known as: (z)-3-(4-chloroanilino)-n-(4-chlorophenyl)-2-(3-methylisoxazol-5-yl)prop-2-enamide · Anvylic-3288
Code names: AVL-3288 · CCMI · UCI-4083 · XY-4083

Resolves to

Compound

Structure

InChIKeyVMAKIACTLSBBIY-BOPFTXTBSA-NSMILESCC1=NOC(=C1)C(=C\NC1=CC=C(Cl)C=C1)\C(=O)NC1=CC=C(Cl)C=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with AVL-3288, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.